← Eichor
Study identifier: NCT05168839 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage

Condition: Colorectal Cancer  ·  Sponsor: Centre Hospitalier Universitaire de Besancon

PhasePhase 3
Planned participants1010
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Colorectal cancer (CRC) is the fourth most commonly diagnosed cancer in the world and the third in France. Its incidence is steadily rising in developing nations. Anastomotic leak (AL) is a major problem in colorectal surgery affecting at least 7% of patients operated on for left colonic cancer. It is the most feared complication after colorectal anastomosis, associated with mortality, prolonged hospitalization, impaired health related quality of life (HRQoL) and increased health care costs. Intraoperative fluorescence angiography (IOFA) with indocyanine green (ICG) may help preventing AL. Available studies on the effects of IOFA with ICG are heterogeneous and randomized controlled trial are scarce. Our aim is to demonstrate that IOFA with ICG could lead to a reduction of AL rate after left-sided or low anterior resection with anastomosis for CRC. The FLUOCOL-1 study is the first national, multicenter, single blind, randomized, 2-arm, phase III superiority clinical trial. The primary endpoint is the occurrence of an AL 90 days post-operation. AL is defined as any anastomotic dehiscence with leakage into the pelvic cavity diagnosed upon imaging or at surgical exploration or any isolated pelvic organ-space infection with no evidence of fistula as defined by the International Study Group of Rectal Cancer. The study population will be made of adult patients with left-sided or high rectal cancer scheduled to undergo elective left colectomy or high rectal resection (by open, lapa…

This description comes directly from the study's public registry record.

Talk to the study team

Zaher Lakkis, MD, PhD  ·  +33 3 81 66 83 41  ·  zlakkis@chu-besancon.fr

Jean-Baptiste Pretalli, PhD  ·  +33 3 81 21 81 27  ·  jbpretalli@chu-besancon.fr

Always discuss trial participation with your own doctor first.

Locations (32)

Centre Hospitalier Universitaire Amiens-PicardieAmiens, FranceRecruiting
CH AnnecyAnnecy, FranceRecruiting
Centre Hospitalier Universitaire de BesançonBesançon, FranceRecruiting
Centre Hospitalier Bourgoin-JallieuBourgoin, FranceRecruiting
University Hospital of DijonDijon, FranceRecruiting
Centre Georges François LeclercDijon, FranceRecruiting
Centre Hospitalier Universitaire de GrenobleLa Tronche, FranceRecruiting
Centre Hospitalier Universitaire de LilleLille, FranceRecruiting
Centre lyonnais de chirurgie digestiveLyon, FranceRecruiting
Centre Hospitalier Lyon-SudLyon, FranceRecruiting
Hôpiatl EuropéenMarseille, FranceRecruiting
Hôpital La TimoneMarseille, FranceRecruiting

+ 20 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05168839